Literature DB >> 15604556

Infliximab-induced vitiligo.

Mercedes Ramírez-Hernández, Carlos Marras, Jorge A Martínez-Escribano.   

Abstract

Mesh:

Substances:

Year:  2005        PMID: 15604556     DOI: 10.1159/000081494

Source DB:  PubMed          Journal:  Dermatology        ISSN: 1018-8665            Impact factor:   5.366


× No keyword cloud information.
  7 in total

Review 1.  Paradoxical reactions under TNF-α blocking agents and other biological agents given for chronic immune-mediated diseases: an analytical and comprehensive overview.

Authors:  Éric Toussirot; François Aubin
Journal:  RMD Open       Date:  2016-07-15

2.  Vitiligo during Treatment of Crohn's Disease with Adalimumab: Adverse Effect or Co-Occurrence?

Authors:  Celia Posada; Angeles Flórez; Ana Batalla; Juan José Alcázar; Daniel Carpio
Journal:  Case Rep Dermatol       Date:  2011-02-05

Review 3.  Tumour necrosis factor-α inhibition can stabilize disease in progressive vitiligo.

Authors:  K C Webb; R Tung; L S Winterfield; A B Gottlieb; J M Eby; S W Henning; I C Le Poole
Journal:  Br J Dermatol       Date:  2015-08-25       Impact factor: 9.302

4.  A Type II Segmental Vitiligo Developed under Infliximab Treatment for Ulcerative Colitis.

Authors:  Tae Hyung Ryu; Dong Won Lee; Jae Eun Choi; Hyo Hyun Ahn; Young Chul Kye; Soo Hong Seo
Journal:  Ann Dermatol       Date:  2017-10-30       Impact factor: 1.444

5.  Resolution of post-adalimumab vitiligo with secukinumab in a patient with psoriasis vulgaris.

Authors:  Giovanni Palazzo
Journal:  Oxf Med Case Reports       Date:  2020-01-31

Review 6.  Role of Cytokines in Vitiligo: Pathogenesis and Possible Targets for Old and New Treatments.

Authors:  Paolo Custurone; Luca Di Bartolomeo; Natasha Irrera; Francesco Borgia; Domenica Altavilla; Alessandra Bitto; Giovanni Pallio; Francesco Squadrito; Mario Vaccaro
Journal:  Int J Mol Sci       Date:  2021-10-22       Impact factor: 5.923

7.  Segmental vitiligo after infliximab use for rheumatoid arthritis--a case report.

Authors:  Clarissa Luiza Dalla Bernardina Carvalho; Luciena Cegatto Martins Ortigosa
Journal:  An Bras Dermatol       Date:  2014 Jan-Feb       Impact factor: 1.896

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.